Effects of long‐term oral treatment with a novel estrogen receptor beta agonist on memory, vasomotor, and anxiety outcomes in an EFAD mouse model of Alzheimer's disease.

Autor: Fleischer, Aaron W, Schwabe, Miranda R, Kuehn, Rachel K, Chaudury, Subhabrata, York, Jason, Ladu, Mary Jo, Sem, Daniel S, Donaldson, William A, Frick, Karyn M

Publikováno v: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jun2023 Supplement 1, Vol. 19, p1-2, 2p